References
- Hegelmaier T, Lebbing M, Duscha A, Tomaske L, Tönges L, Holm JB, et al. Interventional Influence of the Intestinal Microbiome Through Dietary Intervention and Bowel Cleansing Might Improve Motor Symptoms in Parkinson’s Disease. Cells. 2020 Feb 6;9(2).
- Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V. Inflammation and immune dysfunction in Parkinson disease. Nature Reviews Immunology. 2022 2022/11/01;22(11):657-73.
- Zhu Y, Yuan M, Liu Y, Yang F, Chen WZ, Xu ZZ, et al. Association between inflammatory bowel diseases and Parkinson’s disease: systematic review and meta-analysis. Neural Regen Res. 2022 Feb;17(2):344-53.
- Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, et al. Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease. Cell. 2016 Dec 1;167(6):1469-80. e12.
- Malattia di Parkinson, nuove speranze terapeutiche dall’alfa-sinucleina. OMAR2021; Available from: https://www.osservatoriomalattierare.it/malattia-di-parkinson/17982-malattia-di-parkinson-nuove-speranze-terapeutiche-dall-alfa-sinucleina.
- Jeong GR, Lee BD. Pathological Functions of LRRK2 in Parkinson’s Disease. Cells. 2020 Nov 30;9(12).
- Hor JW, Lim SY, Khor ES, Chong KK, Song SL, Ibrahim NM, et al. Fecal Calprotectin in Parkinson’s Disease and Multiple System Atrophy. J Mov Disord. 2022 May;15(2):106-14.